NIKA — NIKA PHARMACEUTICALS, INC
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1145604 ·
Last close
$0.41
Market Cap
$429.91M
52W High
$0.98
52W Low
$0.20
ADV30
98
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -19,694 | -19,694 | 9,942 | 2,932 | 340,624 |
| Mar 2026 | 0 | — | -13,359 | -13,359 | 20,637 | 1,530 | 331,624 |
| Dec 2025 | 0 | — | -37,088 | -37,089 | 20,996 | 1,889 | 318,624 |
| Sep 2025 | 0 | — | -7,982 | -7,999 | 23,625 | 6,287 | 284,164 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-80,068
Investing CF
$0
Financing CF
$62,460
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-9,017,369
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-76,810
Pretax Income TTM
$-76,828
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -76,398 | -76,398 | 20,996 | 318,624 | -297,628 | -79,654 |
| Dec 2024 | 0 | -95,792 | -95,792 | 17,934 | 239,164 | -221,230 | -154,932 |
| Dec 2023 | 0 | -64,833 | -64,833 | 19,596 | 101,745 | -82,149 | -64,833 |
| Dec 2022 | 0 | -3,183,715 | -3,183,715 | 864 | 18,180 | -17,316 | -33,715 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | $428.17M | $7.94 | — |
| PRTA | PROTHENA CORP PUBLIC LTD CO | $425.58M | $8.29 | — |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | $443.99M | $4.12 | — |
| AVIR | Atea Pharmaceuticals, Inc. | $414.66M | $5.17 | — |
| CTNM | Contineum Therapeutics, Inc. | $413.96M | $12.56 | — |
News headlines (Yahoo Finance, 1h cache)
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
2026-08-25 14:13 · Yahoo
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
2026-06-04 14:10 · Yahoo
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
2026-03-06 16:58 · Yahoo
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
2025-12-03 16:58 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.